1.02

1.92% -0.02

After Hours: 1.01 -0.01 -0.98%

Notable Labs Ltd (NTBL)

Overview News Price History Discussions Forecast Stock Split

Notable Labs Ltd stock is currently priced at $1.02, with a 24-hour trading volume of 118.90K. It has seen a -1.92% decreased in the last 24 hours and a +6.25% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.05 pivot point. If it approaches the $0.9901 support level, significant changes may occur.

Previous Close:

$1.04

Open:

$1.02

24h Volume:

118.90K

Market Cap:

$9.20M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-18.40%

1M Performance:

+6.25%

6M Performance:

-68.83%

1Y Performance:

+0.00%

1D Range:

$1.01

$1.15

52W Range:

$0.833

$4.24

Notable Labs Ltd Stock (NTBL) Company Profile

Name

Notable Labs Ltd

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

415 851 2410

Address

320 Hatch Drive, Foster City

Employee

Twitter

Next Earnings Date

2024-05-13

Latest SEC Filings

NTBL's Discussions on Twitter

Notable Labs Ltd Stock (NTBL) Latest News

M&T Bank Corp Purchases 5904 Shares of Douglas Emmett, Inc. (NYSE:DEI) - Defense World

Defense World

Notable Labs: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Was Notable Labs Ltd (NTBL)'s session last reading good? – US Post News - US Post News

US Post News

Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024 - Yahoo Finance

Yahoo Finance

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 - PrimePublishers.com

PrimePublishers.com

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 - Informazione.it

Informazione.it

Notable Labs Ltd Stock (NTBL) Financials Data

There is no financial data for Notable Labs Ltd (NTBL). Check out other stocks for more information.

Notable Labs, Inc. is a clinical-stage platform therapeutic company that develops predictive precision medicine for cancer patients. Its precision medicine platform provides HR-MDS patients with bio-simulate treatment, notable predictive tests with accurate treatment results, integration of biology, engineering, and data, and identifies promising clinical therapies with proven efficacy and tolerability. The company also runs drug combination experiments on the tumor and gives a report back to the patient's doctor. Notable Labs, Inc. is based in Foster City, California.